Blog - EverGlade Consulting

EverGlade Insights Blog

Single-dose Vaccine
The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), is seeking innovative ideas and strategies to...
The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Project Proposals (RPP) for "Manufacturing Optimization for Filovirus Monoclonal Antibodies." The RPP was released on June 24, 2024, with proposals due by...
The Advanced Research Projects Agency for Health (ARPA-H) has announced an upcoming solicitation for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts for FY2024. The initiative targets innovative firms capable of...
Biomedical Advanced Research and Development Authority (BARDA) through the Rapid Response Partnership Vehicle (RRPV) initiative released a Request for Project Proposals (RPP) to establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services to...
The Biomedical Advanced Research and Development Authority (BARDA) is spearheading this effort with its innovative On-Demand Manufacturing program. This initiative is designed to revolutionize the production and distribution of MCMs by developing portable, continuous, and...
BARDA has recently unveiled significant updates to its BAA, emphasizing a more refined and responsive approach to public health preparedness. Amendment 4 introduces crucial changes to the Areas of Interest designed to align BARDA’s efforts...

Contact Us

Scroll to Top